Wilson Therapeutics AB (WTX)

Currency in SEK
229.5000
0.0000(0.00%)
Closed·
Showing Wilson Therapeutics AB historical data. For real-time data please try another search
Day's Range
229.5000229.5000
52 wk Range
0.0000229.5000
Key Statistics
Prev. Close
230
Open
229.5
Day's Range
229.5-229.5
52 wk Range
0-0
Volume
-
Average Volume (3m)
23.65K
1-Year Change
0%
Book Value / Share
-
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock

Technical Analysis

Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Sell
Technical Indicators
Strong Sell
Moving Averages
Strong Sell

Wilson Therapeutics AB Company Profile

Wilson Therapeutics AB publ, a biopharmaceutical company, develops various therapies for patients with rare copper-mediated disorders primarily in the United States and the European Union. It is developing its lead product WTX101, a bis-choline tetrathiomolybdate copper-protein binding agent that is in the Phase III clinical studies for the treatment of Wilson disease, as well as pre-clinical studies for the treatment of amyotrophic lateral sclerosis. The company was founded in 2012 and is headquartered in Stockholm, Sweden. As of June 8, 2018, Wilson Therapeutics AB publ operates as a subsidiary of AstraZeneca PLC

Earnings

Latest Release
Feb 22, 2019
EPS / Forecast
-- / --
Revenue / Forecast
-- / --
EPS Revisions
Last 90 days

WTX Income Statement

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2025 - Fusion Media Limited. All Rights Reserved.